Longeveron Inc.
Longeveron Inc. (LGVN) Financial Performance & Income Statement Overview
Analyze Longeveron Inc. (LGVN) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Longeveron Inc. (LGVN) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Longeveron Inc. LGVN financial performance.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $381000.00 | $603000.00 | $773000.00 | $468000.00 |
| Cost of Revenue | $106000.00 | $73000.00 | $91000.00 | $124000.00 |
| Gross Profit | $275000.00 | $530000.00 | $682000.00 | $344000.00 |
| Gross Profit Ratio | $0.72 | $0.88 | $0.88 | $0.74 |
| R&D Expenses | $2.52M | $1.99M | $2.21M | $1.72M |
| SG&A Expenses | $2.94M | $2.82M | $3.13M | $2.12M |
| Operating Expenses | $5.46M | $4.81M | $5.33M | $3.84M |
| Total Costs & Expenses | $5.56M | $4.88M | $5.42M | $3.97M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $0.00 | $242000.00 | $235000.00 | $229000.00 |
| EBITDA | -$5.18M | -$4.04M | -$4.41M | -$3.27M |
| EBITDA Ratio | -$13.60 | -$6.70 | -$5.71 | -$6.99 |
| Operating Income | -$5.18M | -$4.28M | -$4.65M | -$3.50M |
| Operating Income Ratio | -$13.60 | -$7.10 | -$6.01 | -$7.48 |
| Other Income/Expenses (Net) | $170000.00 | $200000.00 | $81000.00 | $87000.00 |
| Income Before Tax | -$5.01M | -$4.08M | -$4.57M | -$3.41M |
| Income Before Tax Ratio | -$13.15 | -$6.77 | -$5.91 | -$7.29 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$5.01M | -$4.08M | -$4.42M | -$3.41M |
| Net Income Ratio | -$13.15 | -$6.77 | -$5.72 | -$7.29 |
| EPS | -$0.34 | -$0.27 | -$0.32 | -$0.52 |
| Diluted EPS | -$0.34 | -$0.27 | -$0.32 | -$0.52 |
| Weighted Avg Shares Outstanding | $14.95M | $14.89M | $13.63M | $6.51M |
| Weighted Avg Shares Outstanding (Diluted) | $14.95M | $14.89M | $13.63M | $6.51M |
The company's financials show resilient growth, with revenue advancing from $468000.00 in Q2 2024 to $381000.00 in Q1 2025. Gross profit remained healthy with margins at 72% in Q1 2025 compared to 74% in Q2 2024. Operating income hit -$5.18M last quarter, sustaining a consistent -1360% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at -$5.18M. Net income dropped to -$5.01M, while earnings per share reached -$0.34. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan